Clinical trial
Dose-finding Study to Investigate the Safety and Immunogenicity of Two…
NCT00161798 · Pfizer, Industry · Completed
Key facts
| NCT number | NCT00161798 |
|---|---|
| Title | Dose-finding Study to Investigate the Safety and Immunogenicity of Two Vaccinations With FSME IMMUN NEW in Healthy Volunteers Aged 6 to 16 Years. |
| Official title | Double-blind, Randomized, Multicenter Dose-finding Study to Investigate the Safety and Immunogenicity of Two Vaccinations With FSME IMMUN NEW in Healthy Volunteers Aged 6 to 16 Years. |
| Lead sponsor | Pfizer, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Tick-borne Encephalitis |
| Intervention type | Biological |
| Interventions | Tick-borne encephalitis vaccine |
| Start date | Sep 1, 2001 |
| Completion | Mar 1, 2002 |
| First posted | Sep 13, 2005 |
| Last update posted | May 21, 2015 |
| Countries | Germany |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: